Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company

Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company

BioSpace Global Roundup, Oct. 29

BioSpace Global Roundup, Oct. 29

Armata Pharmaceuticals Issues Letter to Shareholders – Oct 29, 2020

Armata Pharmaceuticals Issues Letter to Shareholders - Oct 29, 2020

Kezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the...

Kezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis and Dermatomyositis

Retrophin Announces Agreement to Acquire Orphan Technologies

Retrophin Announces Agreement to Acquire Orphan Technologies
- Advertisement -

LATEST NEWS

MUST READ